Novo Nordisk A S
NONOF- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000353278
No open-market purchases or sales by Novo Nordisk A S insiders were filed in the last 90 days; 3 institutions reported holding it in 13F filings for Q2 2026, worth $5.36M in total; no superinvestor holds it.
Other share classesNVO
Q4 2024 vs. Q3 2024
How the institutions holding Novo Nordisk A S changed between Q3 2024 and Q4 2024.
All holders in Q4 2024All holders in Q3 2024
| Measure | Q3 2024 | Q4 2024 | Change |
|---|---|---|---|
| Holders | 2 | 3 | +1 |
| Shares | 5.48K | 16.2K | +10.7K (+195.9%) |
| Value | $643.4K | $1.39M | +$748.7K (+116.4%) |
New holders (1)
Institutions that held Novo Nordisk A S at the end of Q4 2024 but not at the end of Q3 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| LBMC Investment Advisors, LLC | 10,210 | $877.0K | 0.07% |
Sold out (0)
Institutions that held Novo Nordisk A S at the end of Q3 2024 and filed for Q4 2024 without it.
None.